Centre Hospitalier de l'Université de Montréal
Montreal, Quebec, Canada
26 recruiting
Showing 1–20 of 46 trials
Recruiting
Not Applicable
Reducing Neoplasia Recurrence After Endoscopic Resection of Large Colorectal Polyps
Colorectal, CancerPolyp of Colon
Centre hospitalier de l'Université de Montréal (CHUM)892 enrolled1 locationNCT06271941
Recruiting
Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis
Nonalcoholic Steatohepatitis (NASH)Nonalcoholic Fatty Liver Disease (NAFLD)
Centre hospitalier de l'Université de Montréal (CHUM)102 enrolled1 locationNCT03572465
Recruiting
Not Applicable
Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients
ALS (Amyotrophic Lateral Sclerosis)ALSFTDFrontal Temporal Dementia (FTD)
Centre hospitalier de l'Université de Montréal (CHUM)150 enrolled3 locationsNCT06051123
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Breast CancerLung Cancer
Bristol-Myers Squibb416 enrolled61 locationsNCT06618287
Recruiting
Phase 2Phase 3
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Untreated, Unresectable, or Metastatic Colorectal Cancer
Bristol-Myers Squibb990 enrolled281 locationsNCT07221357
Recruiting
Not Applicable
Complete Closure After Endoscopic Mucosal Resection of Large Non-Pedunculated Colorectal Polyps
Colorectal, CancerPolyp of Colon
Centre hospitalier de l'Université de Montréal (CHUM)686 enrolled1 locationNCT06807073
Recruiting
Evaluation of Technological Innovation in Radiotherapy
Radiotherapy Side EffectCancer
Centre hospitalier de l'Université de Montréal (CHUM)1,500 enrolled5 locationsNCT03378856
Recruiting
WRAP North America
Venous StenosisVenous Occlusion
Merit Medical Systems, Inc.250 enrolled16 locationsNCT06807099
Recruiting
Phase 2
Adaptive RadioTherapy for OroPharynx Cancer
Radiotherapy Side EffectMRIRadiotherapy; Complications+2 more
Centre hospitalier de l'Université de Montréal (CHUM)120 enrolled2 locationsNCT04901234
Recruiting
Phase 3
Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer
Head and Neck CancerOropharynx CancerHuman Papilloma Virus
Centre hospitalier de l'Université de Montréal (CHUM)360 enrolled2 locationsNCT04178174
Recruiting
Phase 3
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Metastatic Castration-resistant Prostate Cancer
Pfizer900 enrolled237 locationsNCT06629779
Recruiting
Phase 2
Post-operative Radiotherapy After Neodjuvant Chemo-immunotherapy and Surgery in Stage III NSCLC
Non-small Cell Lung CancerStage III Lung Cancer
Centre hospitalier de l'Université de Montréal (CHUM)118 enrolled1 locationNCT06878274
Recruiting
Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies
Radiotherapy Side EffectCancer
Centre hospitalier de l'Université de Montréal (CHUM)3,600 enrolled1 locationNCT04115267
Recruiting
Lesion Size Measurement During Gastrointestinal Endoscopies
Crohn DiseasePolyp of Colon
Centre hospitalier de l'Université de Montréal (CHUM)3,000 enrolledNCT07770425
Recruiting
Not Applicable
Endovascular Acute Stroke Intervention - Tandem OCclusion Trial
Stroke, AcuteCarotid StenosisCarotid Artery Diseases
Centre hospitalier de l'Université de Montréal (CHUM)458 enrolled1 locationNCT04261478
Recruiting
Phase 3
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Prostate CancerCancer of the ProstateHormone Sensitive Prostate Cancer+1 more
Pfizer1,000 enrolled341 locationsNCT07028853
Recruiting
Phase 3
Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease
Steno-occlusive Disease
Guerbet315 enrolledNCT07348640
Recruiting
Video/Image Library of Endoscopy Procedures for the Development of AI-empowered Endoscopy Quality Reporting and Educational Modules
Artificial Intelligence (AI)Polyp of Colon
Centre hospitalier de l'Université de Montréal (CHUM)10,000 enrolled1 locationNCT06822816
Recruiting
Phase 2Phase 3
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Breast Neoplasms
Bristol-Myers Squibb600 enrolled295 locationsNCT06926868
Recruiting
Phase 2
Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer
Metastatic CancerOligoprogressive
Centre hospitalier de l'Université de Montréal (CHUM)46 enrolled1 locationNCT04989725